SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?


To: m. jacobs who wrote (4040)6/24/1999 4:14:00 PM
From: AriKirA  Read Replies (2) | Respond to of 8117
 
We really appreciate your efforts M Jacobs. It isn't easy trying to run a company... that's why shareholder's sometimes try to help management by underlying certain elements that need to be changed. Thank you for taking Jack's comments seriously. Sometimes a person speaks for several people... One must remember we're all on the same team. Once in a while we forget that!

Many Thanks to management!
AK



To: m. jacobs who wrote (4040)6/24/1999 11:31:00 PM
From: Jack Rayfield  Respond to of 8117
 
Mr. Jacobs

I really appreciate the fact that the home page change was made before the Expo. I look forward to other updates in the coming weeks. I hope that things went well at the Expo. It looks like a great opportunity. If you get a chance let us know how it went.

I think a summary of total uses to date would be a great page. Since the poster presentation addresses the first 50 uses it would be nice to know how the entire field test database breaks down. Possible data categories of interest are:

conscious versus unconscious uses
EMS versus ER
conditions it was used in the treatment of: cardiac arrest, drug overdose, other trauma
Uses by field test site
Uses by Arizona Heart Hospital before open surgery
Any other breakout of information included in the data submitted by the field test sites

Just a thought. Thanks for all the hard work. And I look forward to hearing great things from the Expo and Pyng's receipt of the press/analyst coverage it deserves.

Good luck
Jack